{"id":15195,"date":"2023-09-21T12:11:12","date_gmt":"2023-09-21T12:11:12","guid":{"rendered":"https:\/\/prosfunds.com\/markets\/which-is-a-better-pick-corning-stock-or-west-pharmaceutical-services\/"},"modified":"2023-09-21T12:11:14","modified_gmt":"2023-09-21T12:11:14","slug":"which-is-a-better-pick-corning-stock-or-west-pharmaceutical-services","status":"publish","type":"post","link":"https:\/\/prosfunds.com\/?p=15195","title":{"rendered":"Which Is A Better Pick \u2013 Corning Stock Or West Pharmaceutical Services?"},"content":{"rendered":"
\n

We believe that Corning stock<\/strong> (NYSE: GLW) is currently a better pick West Pharmaceutical Services stock<\/strong> (NYSE: WST), a global solutions provider for drugs, biologics, gene therapies, and consumer healthcare products. Although these companies are from different sectors, we compare them because they have a similar market capitalization of around $30 billion.<\/p>\n

Interestingly, GLW has had a Sharpe Ratio of 0.2<\/strong> since early 2017, lower than the 0.9 <\/strong>figure for WST and 0.6<\/strong> for the S&P 500 Index over the same period. This compares with the Sharpe of 1.3<\/strong> for the Trefis Reinforced Value portfolio. Sharpe is a measure of return per unit of risk, and high-performance portfolios can provide the best of both worlds.<\/p>\n

The decision to invest often comes down to finding the best stocks within the parameters of certain characteristics that suit an investment style. The size of profits can matter, as larger profits can imply greater market power. Since these stocks are from different sectors, comparing P\/S against one another may not be helpful. We compare their current multiples with the historical ones in the sections below to better gauge their valuations.<\/p>\n

Looking at stock returns, WST has outperformed GLW and the broader markets amid the upbeat performance of its proprietary products business. While GLW is down 1% this year, the S&P500 index is up 16%, and WST is up a stellar 68%. There is more to the comparison, and in the sections below, we discuss why we believe that GLW will offer better returns over WST in the next three years. We compare a slew of factors, such as historical revenue growth, returns, and valuation, in an interactive dashboard analysis of Corning vs. West Pharmaceutical Services<\/strong>
\n WST
\n <\/fbs-ticker>: Which Stock Is A Better Bet?<\/strong> Parts of the analysis are summarized below.<\/p>\n

<\/fbs-ad><\/p>\n

1. West Pharmaceutical Services\u2019 Revenue Growth Is Better<\/strong><\/p>\n